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On 10 December 2020 Donna Ockenden (midwife) 
published emerging findings from the Independent 
Review of Maternity Services at the Shrewsbury and 
Telford Hospital NHS Trust where allegedly avoidable 
maternal and infant deaths had occurred. The early 
report was a clear indicator of the need for immediate 
action and this was after a review of 250 cases from 
a potential of 1862 cases. It was a sobering read and 
the urgency of the need for immediate action was loud 
and clear. As I read through the recommendations 
I was struck by the numerous references to fetal 
monitoring and in particular:
‘4.22 Fetal heart rate (FHR) monitoring is an essential 
component of the safe management of labour ... 
The review team found significant problems with 
the conduct of intermittent auscultation and in the 
interpretation of CTG … [Cardiotocograph]’
‘4.26 A mother, admitted in labour with a breech 
presentation, had inappropriate use of oxytocin for 
her long labour with CTG concerns …’
‘4.27 A woman presented in labour at 39 weeks. 
There were CTG abnormalities in labour, which  
were not escalated …’
(Ockenden 2020).
The memories of hours of observation of 
induced labours and the use of the continuous 
cardiotocography (CTG) machine flooded my 
thoughts. In my early research exploring the role of 
the CTG machine in the lifeworld of technologically 
supported midwifery practice, its place was securely 
positioned as a necessity for use in births where 
induction of labour was the status quo (Sinclair 
1999). In 2009, 10 years later, the polarised opinions 
of midwives in midwife-led care settings and those 
in hospital settings were apparent — with the 
latter more favourably disposed towards the use of 
technology. It would be good to replicate the study 
in 2021.The role and model of the CTG machine 
has changed considerably during the last 20 years 
with much more sophisticated and less bulky fetal 
monitoring devices available off the shelf and, 
recently, more computerised software additions have 
received a favourable review (Judd et al 2020).
With the increased availability of clinical/health/
hospital video consultations using downloadable 
desktop and mobile apps, such as PEXIP, the 
opportunities for remote monitoring of pregnant and 
labouring women during COVID-19 have escalated. 
Video consultation technology offers enhanced care 
for women and their babies and facilitates midwives 
to care for women while reducing the risks associated 
with attending maternity clinics. However, in 
reminiscing about the old, large, bulky CTG models, 
I still hold fond memories of the interviews with 
midwifery managers when exploring their perceptions 
of the arrival of the CTG machine in the 1970s. 
The image of one midwifery manager, in particular, 
is embedded in my memory as she smoked her 
way through the interview while she gave the most 
beautifully illustrated description of her memory of 
the CTG machine’s glorious arrival to the labour ward 
and how it was greeted with respect and anticipation 
when it was proudly wheeled down the ward by 
the doctor shrouded in a white sheet. Mothers were 
delighted with the new high technology and enjoyed 
hearing their baby’s heartbeat. The CTG machine was 
welcomed by midwives because it was going to be 
an important tool in the midwifery decision making 
process and it was going to enable doctors to make 
clinical decisions to intervene early to reduce neonatal 
mortality (Sinclair 1999).
The multi-professional team’s expectations of the 
machine’s capabilities were, however, beyond its 
capacity to deliver and the situation today has not 
changed. Although innovation in design has overcome 
some of the restrictions to a woman’s need to be 
mobile during labour when monitoring is necessary, 
the CTG machine is limited by the product hardware 
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design and the functions of the program software.  
It is, therefore, impossible for any CTG machine to be 
100 per cent accurate in determining abnormal fetal 
heart rate patterns and alerting clinical midwives and 
doctors to consider early/instrumental intervention. 
Even the more sophisticated high-tech models cannot 
be programmed to take into consideration every 
human variable likely to impact on fetal well-being, 
including gestation, fetal weight, fetal anomalies, 
maternal health and social issues, familial traits, 
medication and drug history. The human decision 
making remains the same and I see similarities in 
expectations of novice researchers who anticipate that 
by loading up their masses of interview data into a 
software package, such as NVIVO, the machine will 
magically produce a perfect data analysis output. 
How wrong they are!
Every doctoral midwife using software needs to be 
aware of the limitations of the machine to interpret 
results in context. The package is excellent for 
managing large volumes of qualitative data. You put 
the data in and you direct the action of the program 
to produce the data output and YOU are the one who 
must make the interpretation judgement when the 
software churns out patterns and nodes and clusters 
of data. The data has to be analysed in context 
and a researcher has to bear in mind the original 
research questions, the aim of the study and the 
specific objectives framing the data entries. You, as 
the researcher, have already imposed a framework of 
pre-determined questions for interviews and the data 
needs to be interpreted bearing this factor in mind. 
When we transfer our thinking to the outputs from 
the CTG machine, we need to be cognisant of the 
fact that the software program has limitations and 
will be designed using data available from previously 
screened mothers’ CTG readings. Therefore, an 
ability to discriminate between different clinical 
conditions, ethnic origins and social groupings 
cannot be expected at this time. The data produced 
is limited to each mother and baby dyad. The newer 
machines, designed to provide clinical alerts using a 
traffic light system, are also limited even though they 
have more sophisticated artificial intelligence. The 
machine cannot give a 360-degree holistic analysis 
of maternal and fetal well-being and it is not yet 
designed to discriminate for social groupings, women 
with medical issues or ethnic factors. Fetal heart rate 
is indeed a key variable but on its own, without the 
fetal PH and the maternal pulse, BP and temperature 
it is severely limited.
Data from the CTG machine is just one segment of 
the full picture and needs to be viewed with that lens; 
our expectations need to be realistic. Based on the 
recommendations for immediate action with regard 
to appropriate and effective fetal monitoring from 
the Ockenden (2020) report, there is a continued 
need for multi-professional certified competence in 
CTG application and interpretation with support for 
colleagues undertaking fetal well-being monitoring. 
I would go further to say that midwives and 
obstetricians need to become more involved in the 
actual design of the software to ensure the sensitivity 
and specificity of the future computerised programs 
are enhanced.
Many times I have been in discussion with academic 
and clinical colleagues on the role of the CTG 
machine as a helpful tool for midwives and a source 
of reassurance for mothers and fathers and a useful 
learning resource for student midwives. I hear, 
again and again, that the machine leads to increased 
caesarean section and instrumental delivery based on 
Cochrane review (Alfirevic et al 2017) but many fail 
to critically read the authors’ conclusions:
‘The question remains as to whether future 
randomised trials should measure efficacy (the 
intrinsic value of continuous CTG in trying to 
prevent adverse neonatal outcomes under optimal 
clinical conditions) or effectiveness (the effect of this 
technique in routine clinical practice).’ (Alfirevic et al 
2017:1).
The effectiveness of the technique is in our domain 
of practice. We are also the main interpreters of the 
data outputs and we are the people who initiate active 
interventions based on our judgement of the evidence 
presented.
I find myself asking the question: ‘Have we lost our 
skill in CTG interpretation or are we so focused on 
normality that we are unable to conceive of fetal 
monitoring as an essential component of our skill 
set?’ Furthermore: ‘Are we listening to women who 
request continuous fetal monitoring?’ I have spoken 
to mothers who had previous stillbirths and for 
them and their partners, the CTG machine provided 
evidence that their baby was alive. Many women 
have purchased various fetal heart ‘recorders’ over 
the internet. Stories from family and friends provide 
anecdotal data on how some women, and some 
midwives, feel the value of the CTG is not just in 
aiding clinical decision making but provides much-
needed psychological support that women need even 
more during COVID-19. The threat of face-to-face 
contact is real and in the current pandemic, three UK 
midwives and five mothers have already died from 
COVID-19 (Knight et al 2020, Cook et al 2020). The 
pandemic has definitely had a huge impact on the use 
of the internet and online platforms that are becoming 
more attractive to midwives and mothers as they 
provide several benefits, including acting as a safety 
net in reducing the risk of exposure to COVID-19. I 
do hope 2021 will be a year in which we use the full 
range of technologies available to us appropriately 
and effectively for the good of the mothers and babies 
we serve — whether that be online communication 
via Facebook, WhatsApp, Live Chat, Skype, Zoom 
or through the use of supportive, surveillance 
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technologies, such as the CTG machine, or alternative 
maternal and fetal monitoring equipment.
I am certain that the future of fetal monitoring in 
2021 is going to have a major overhaul and we must 
implement the findings from the Ockenden report 
(2020):
‘… all maternity services must appoint a dedicated 
lead midwife and lead obstetrician with expertise 
in the field of foetal monitoring in order to improve 
upon practice in foetal monitoring.’
Professor Marlene Sinclair (editor)
PhD, MEd, PGDip/Ed, BSc, RM.
Professor of Midwifery Research and Head of the 
Centre for Maternal, Fetal and Infant Research at 
Ulster University, Northern Ireland.
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Background: There is a wide spectrum of perinatal mental health (PMH) disorders 
including anxiety, depression, stress, compulsive disorders, post-traumatic stress disorder 
(PTSD), mania and postpartum psychosis. Up to 20 per cent of women are found to be 
suffering from anxiety and or depression during pregnancy and the first three months 
postnatally. Maternal mental health can have an impact on the infant both antenatally and 
throughout the life course, with social, emotional and cognitive consequences. Therefore, 
there is a critical need for evidence-based interventions which address PMH disorders. 
At present, cognitive behavioural therapy (CBT) and eye movement desensitisation and 
reprocessing therapy (EMDR) are the most commonly used therapies. They remain the only 
psychotherapies for PTSD in the perinatal period approved by The National Institute for 
Health and Care Excellence (NICE 2014).
Objective: To assess the effectiveness of online psychotherapy (O-P-T) interventions for the 
treatment of PMH disorders.
Methods: To address the research question ‘What is the effectiveness of online 
psychotherapy interventions for the treatment of perinatal mental health disorders?’ 
the researchers developed eligibility criteria using the Cochrane PICOS framework. Five 
electronic databases were searched: PsycInfo, MEDLINE, CINAHL Complete, ProQuest 
Dissertations & Theses and Scopus, along with Google Scholar and the Shapiro Library, to 
identify papers which investigated O-P-T interventions published before July 2020.
Interventions were included if study participants had a clinician-assessed diagnosis of 
a PMH illness at screening and if the study had an experimental design with clinician 
involvement as part of the intervention. The included studies were assessed for quality 
using the standard quality assessment criteria for evaluating primary research papers from 
a variety of fields (QualSyst) (Kmet et al 2004).
Findings: Searches yielded 2567 results from the selected databases. Five studies 
were included in the review (209 participants), three were postnatal depression (PND) 
interventions and two were antenatal depression (AD) interventions. All were CBT-based. 
Quality ratings of the included studies were found to be high based on QualSyst scores, 
however treatment fidelity was not reported. Pooled effect sizes found a small to medium 
effect favouring the intervention versus control on the reduction of depressive symptoms, 
according to their score on the selected depression measures, and in some cases remission 
(d=0.48, 95% CI -0.07, 1.06). The results from the pooled effect sizes on available within-
group data resulted in a large treatment effect for depression, anxiety and stress outcomes 
(d=1.90; d=0.81; d=1.05). Attrition rates were comparable with other online psychotherapy 
studies for mental health.
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ABSTRACT
Conclusions: This review provides evidence that O-P-T interventions for the treatment of 
PMH disorders are effective in improving clinical outcomes in the reduction of depression, 
anxiety and stress. Despite NICE (2014) recommendations for the treatment of PTSD in 
the perinatal period there remains a gap in the literature for online EMDR interventions. In 
addition, there is a lack of research for O-P-T interventions delivered via different modalities, 
such as videoconferencing, and a scarcity of research into O-P-T for other PMH disorders.
This is the first synthesis of research into O-P-T for women who meet diagnostic criteria 
for PMH disorders as classified by the International Classification of Diseases (ICD-11) 
(World Health Organization (WHO) 2020) or the Diagnostic and Statistical Manual of Mental 
Disorders (DSM-5) (American Psychiatric Association 2013).
Keywords: perinatal, online, systematic review, mental health, EMDR, interventions, 
psychotherapy, Evidence Based Midwifery
Introduction
According to the International Classification of 
Diseases 11th Revision (ICD-11) (WHO 2020) 
the perinatal period covers pregnancy and up to a 
year after birth. For many women, this is a time of 
excitement and hope for the future. However, this 
is not the case for every family as some of the most 
common morbidities associated with this period 
are mental health disorders (Howard et al 2014). 
There is a wide spectrum of perinatal mental health 
(PMH) disorders including anxiety, stress, depression, 
compulsive disorders, post-traumatic stress disorder 
(PTSD), mania and postpartum psychosis. Up to 20 per 
cent of women are found to be suffering from anxiety 
and or depression during pregnancy and the first three 
months postnatally (O’Hara & Wisner 2014).
The psychological and economic costs associated with 
PMH disorders are substantial and the effects extend 
beyond the woman (Bauer et al 2014). Maternal 
mental health can have an impact on the infant 
both antenatally and throughout the life course, 
with social, emotional and cognitive consequences 
(Goodman 2019). Research has identified links 
between depression in the pregnancy period and 
obstetric complications such as low birth weight, 
increased risk of caesarean section and preterm birth 
(Huang et al 2017). Additionally, prenatal depression 
and prenatal anxiety have been associated with poor 
breastfeeding outcomes (Fallon et al 2016). PMH 
disorders have also been found to be the leading 
cause of suicide in pregnancy and in the first year 
after birth, with suicide in this period accounting for 
between five and 20 per cent of maternal deaths in 
high-income countries (Khalifeh et al 2016, Knight 
et al 2019). Consequently, the economic cost of 
perinatal anxiety, depression and psychosis combined 
are reported to amount to £8.1 billion per each one-
year cohort of births in the UK, equating to almost 
£10,000 for every birth (Bauer et al 2014).
Given the impact PMH disorders have, it is critical 
that women receive timely treatment to ensure 
positive outcomes for both mother and infant. 
Research investigating women’s intentions for help-
seeking has identified that they are more inclined to 
seek informal help from partners or family than seek 
professional help (Fonseca & Canavarro 2017). This 
could be interpreted as due to the perceived barriers 
to treatment that women cite, such as lack of time, 
lack of childcare and the costs involved (Lara et al 
2014, Masood et al 2015, Millett et al 2018). An 
equally salient barrier to help-seeking for PMH is 
the perception of stigma, feelings of guilt and shame. 
Women have been found to express a fear of being 
judged as a bad mother and to fear the prospect that 
their children could be taken away if they are deemed 
unable to cope (Millett et al 2018).
Of central concern, therefore, are ways in which 
barriers to accessing treatment/support can be 
ameliorated to provide women with a safe, effective 
and practical way to access help in the perinatal 
period. Recent research into online psychotherapy 
(O-P-T) has found that individuals report that the 
ability to access therapy from home can reduce the 
stigma associated with attending in person, eliminate 
travel costs (Sunjaya et al 2020) and alleviate 
childcare issues (Millet et al 2018).
There is a paucity of research looking at the efficacy 
of O-P-T. To the authors’ knowledge there are 
currently no systematic reviews specifically examining 
the efficacy of O-P-T for women who have a clinical 
diagnosis of a perinatal disorder. Additionally, the 
recent impact of the global COVID-19 pandemic has 
emphasised the importance of individuals being able 
to access online therapy. With a widespread increase 
in acceptance of telehealth from mental health 
professionals and the wider community (Wind et al 
2020), conducting a review to assess the efficacy of 
O-P-T in this population is warranted. Therefore, 
the aim of this review was to provide a synthesis 
of current evidence for effective psychotherapeutic 
interventions delivered via online modalities for 
women with a PMH diagnosis.
Methods
Search strategy
The following databases were searched systematically 
on 26 March 2020: PsycInfo, MEDLINE, CINAHL 
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Complete, Proquest Dissertations & Theses, Scopus. 
In addition, searches in Google Scholar and the 
Shapiro Library were carried out. A combination of 
search terms and medical subject headings (MeSH) 
terms related to the topic were used, such as ‘mental 
health’, ‘perinatal’, ‘psychotherapy’, and ‘online’ to 
search article titles, abstracts and keywords. The 
list of search terms was adapted from a previous 
systematic review by Ashford et al (2016) with the 
help of a subject matter expert librarian. The Google 
Scholar search strategy involved taking the first 10 
pages of results from a search of the following terms: 
‘perinatal AND mental health diagnosis AND online 
AND psychotherapy’. This search strategy was based 
on a previous systematic review which limited the 
number of Google Scholar pages used for selecting 
papers (Sinclair et al 2018). In addition, reference lists 
of the included papers were searched for any other 
eligible articles and search alerts were set up on the 
databases to provide any new relevant publications.
Selection process and eligibility criteria
Following the database searches, duplicates were 
removed prior to title and abstract screening for 
eligibility. The eligibility criteria were developed using 
the Cochrane PICOS framework (O’Connor et al 
2008) (see Table 1).
Studies were excluded if interventions were a) 
self-guided without therapist involvement b) had 
pharmacological co-interventions and c) consisted 
of only telephone or SMS (text) therapy. Study 
protocols, qualitative studies and studies in which less 
than half of the population met the criteria were also 
not eligible for review. Agreement on eligibility for 
inclusion involved discussion with five of the authors 
at both abstract and full-text screening stages.
Study selection
The database searches yielded a total of 2566 papers; 
one more paper was identified from one of the 
authors’ recent reading sources. Two thousand five 
hundred and nine titles and abstracts were screened 
after duplicates were removed. A total of nine full 
texts were screened, with five being deemed eligible 
for review. Study screening and selection followed 
the Preferred Reporting Items for Systematic Reviews 
and Meta-Analyses (PRISMA) guidance (Moher et al 
2009) (see Figure 1).
Data extraction
A data extraction form was devised to enable 
the following data to be extracted: authors, 
year, aims/objectives, study design, participant 
inclusion/exclusion criteria, recruitment, sampling, 
randomisation, blinding, intervention (including 
integrity, duration, content and therapist 
involvement), comparator, statistical methodology, 
outcome measures, and results (main outcomes, 
attrition, power analysis, treatment compliance).
After reviewing the data and considering the studies’ 
methodological design, intervention designs and 
outcome measures, it was deemed too heterogeneous 
to conduct a meta-analysis and therefore the review 
takes a narrative approach.
Findings
Study characteristics
All studies were primary research papers published in 
peer-reviewed journals. There was variability in the 
sample sizes, study origins, recruitment methods and 
attrition rates. An overview of study characteristics 
can be found in Table 3.
Study design
Four of the five studies used a parallel randomised 
controlled (RCT) design (Milgrom et al 2016, Pugh et 
al 2016, Forsell et al 2017, Wozney et al 2017) with 
the remaining paper adopting a quasi-experimental 
design without control group (Kim et al 2014). Each 
study assessed the efficacy of the intervention through 
measuring outcomes at varied timepoints.
Study sample
The total number of participants across the studies 
was 209, with sample sizes ranging from 12 to 62. 
Fifty-four of the 209 participants were women in the 
antenatal period and 155 were postnatal women. 
Attrition rates ranged from five per cent to 40 per cent 
from the point of randomisation or time 1 (T1) to 
final post-intervention timepoint. All participants were 
over the age of 19, however, due to heterogeneity in 
the reporting of participant age, it was not possible to 
determine the range. The recruitment method adopted 
by the majority of studies was self-referral through 
advertising (Milgrom et al 2016, Pugh et al 2016, 
Forsell et al 2017). Two studies used a combination 
Table 1. PICOS framework.
PICOS Description
Population Women in the perinatal period (start of pregnancy to one year postpartum) who have been diagnosed with a 
perinatal mental health disorder as defined by the ICD-11/DSM-5.
Interventions Evidence-based online (computer/web-based) psychotherapies to treat mental health issues in the  
perinatal period. 
Comparisons Face-to-face treatment, treatment as usual (TAU), waitlist, pre-test/post-test outcome results.
Outcomes Improved clinical outcomes, adverse effects, attrition rates.
Study design Experimental designs e.g. randomised controlled trials, pre-post quasi-experimental design.
8The Royal College of Midwives, Evidence Based Midwifery 19(1): 6-18
Black R, Sinclair M, Miller P, Reid B, McCullough J, Slater P, Stein M T, Farrell D (2021). The effectiveness of online psychotherapy interventions for 
the treatment of perinatal mental health disorders: a systematic review. Evidence Based Midwifery 19(1): 6-18
of self-referral and referral through a health care 
professional (Kim et al 2014, Wozney et al 2017). Out 
of the participant samples, 155 were either married, 
co-habiting, engaged or in a committed relationship.
Methodological quality assessment
Study quality of the included papers was assessed 
using the standard quality assessment criteria for 
evaluating primary research papers from a variety of 
fields (QualSyst) (Kmet et al 2004). This is a 14-item 
checklist rated on a four-point scale: yes=2, partial=1, 
no=0, and N/A. With a total possible sum score out 
of 28 (less *2 for checklist items not applicable to 
the study design), summary scores were calculated by 
dividing the total sum score with the total possible 
score. This provided the authors with an assessment 
score of methodological quality in which a higher 
score represented higher methodological quality. 
In order to ensure rigour, quality assessment was 
assessed independently by five of the authors and 
discussed until agreement was reached.
Overall the studies were 
all found to score highly 
on the methodological 
rating according to 
QualSyst (Kmet et al 
2004). Table 2 provides a 
breakdown of the ratings 
each study was allocated 
by the reviewers on 
each of the 14 criteria. 
The main limitations 
were found to be risk 
of response bias due to 
self-report scales, lack of 
blinding to investigators, 
inadequate sample 
size and the possible 






The two PMH 
disorders targeted by 
the interventions were 
antenatal depression 
(AD) (Kim et al 2014, 
Forsell et al 2017) and 
postnatal depression 
(PND) (Milgrom et al 
2016, Pugh et al 2016, 
Wozney et al 2017). 
All interventions used 
cognitive behavioural 
therapy (CBT) as a 
therapeutic approach 
to develop online self-guided modules with therapist 
support.
There was heterogeneity in the content of support and 
delivery method, with two interventions providing 
telephone support (Milgrom et al 2016, Wozney et al 
2017), one intervention blending face-to-face (F2F) 
therapy with online modules (Kim et al 2014) and 
two delivering support through email communication 
(Pugh et al 2016, Forsell et al 2017). Duration and 
frequency of delivery varied from seven to 12 modules 
at a rate of one per week. There was substantial 
variability in the content of the online element of each 
intervention programme. More information on each 
intervention can be found in Table 3.
Additionally, the comparison groups in each RCT 
study ranged from waitlist control group (WLC) 
(Pugh et al 2016) to treatment as usual (TAU) with 
information on depression (Wozney et al 2017), 
TAU with optional intervention following the 
study (Forsell 2017), TAU with no information or 






















Figure 1. PRISMA flowchart of study selection.
Additional records identified 
through hand searches and 
alerts (n = 1)
Records identified through 
database searching  
(n = 2566)








Records excluded,  
with reasons 
(n = 2500)
- Not primary research 
- Not perinatal focused 
- Not online studies 
- Not psychotherapy 
- Study protocols
Full-text articles 
assessed for eligibility 
(n = 9)
Full-text articles 
excluded, with reasons 
(n = 4)
- No PMH diagnosis -3 
- Not all in perinatal 
period -1
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Country of origin
The studies were undertaken in four different 
countries: two in Canada (Pugh et al 2016, Wozney 
et al 2017); one in Sweden (Forsell et al 2016); one 
in the United States of America (Kim et al 2014) and 
one in Australia (Milgrom et al 2016).
Mental health outcomes
Where possible, continuous measures were converted 
to a standardised effect size (Cohen’s d) (Cohen 1988) 
using standardised mean difference; dichotomous 
data were converted from chi-squared results. This 
enabled the production of forest plots to report 
between-group (intervention versus control) effect 
sizes for mental health outcomes (see Figure 2) and 
within-group effects for mental health outcomes in 
the intervention group (see Figure 3). Where data 
was not available, study authors were contacted and 
if data was not provided the study outcomes were 
omitted from the forest plot. 
As demonstrated in Figure 2, the results from the 
pooled effect sizes show that the majority of mental 
health outcomes favoured the intervention with the 
exception of DASS-Stress and DASS-Depression in the 
study by Pugh et al (2016). Reduction of depression 
symptoms and diagnosis was approaching a medium 
overall effect size (d=0.48 CI -0.07, 1.06), anxiety 
symptom reduction had a small overall effect (d=0.35 
CI -0.36, 0.81) and total stress reduction saw a 
negative small effect size (d=-0.23 CI -0.08, 1.14).
The results from the pooled effect sizes on available 
within-group data show a large treatment effect 
for depression, anxiety and stress (d=1.90; d=0.81; 
d=1.05)
The primary outcome in all studies was depression, 
with each study using a number of different 
depression measures. Three out of five studies 
assessed clinical diagnostic status of depression at 
baseline using the SCID-I (Kim et al 2014, Forsell 
et al 2017, Wozney et al 2017) and one used the 
SCID-IV (Milgrom et al 2016). Pugh et al (2016) 
assessed diagnostic status at baseline using the MINI 
International Neuropsychiatric Interview. 
Only two studies followed up by assessing post-
intervention clinical diagnosis using the same 
clinician-administered instrument (Milgrom et al 
2016, Wozney et al 2017). Remission rates in the 
RCT treatment groups post-intervention and follow 
up ranged from 33 per cent to just over 90 per cent 
(Milgrom et al 2016, Pugh et al 2016, Forsell et al 
2017, Wozney et al 2017). In the quasi-experimental 
study by Kim et al (2014), 60 per cent of participants 
were deemed in remission.
Kim et al (2014) reported the Hamilton Depression 
Rating Scale (HDRS) as their primary outcome 
measure and found a large significant effect size 
(d=2.38, 95% CI 1.30 – 3.31) at eight weeks post-
treatment. Forsell et al (2016) assessed depression 
using the Montgomery-Åsberg Depression Rating 
Scale-Self report version (MADRS-S) and found large 
significant between-group post-treatment effect sizes 
(g=1.21, 95% CI, 0.50- 2.92).
The Beck Depression Inventory (BDI and BDI-II) was 
reported in three studies (Kim et al 2014, Milgrom 
et al 2016, Wozney et al 2017). Kim et al (2014) 
reported a significant reduction in BDI scores at 
eight weeks with a large effect size (d=2.47, 95% CI 
1.37- 3.42). Similarly, Milgrom et al (2016) found a 
significant reduction in between group BDI-II scores 
Table 2. Quality assessment of included studies.
Kim et al  
2014
Milgrom et al  
2016
Pugh et al  
2016
Forsell et al  
2017
Wozney et al  
2017
1) Question/objective sufficiently described? 2 2 2 2 2
2) Design evident/appropriate? 1 2 2 2 2
3) Participant selection described/appropriate? 2 1 1 1 2
4) Participant characteristics/input variables  
sufficiently described?
2 2 2 2 2
5) Random allocation described? N/A 2 2 2 2
6) Investigator blinding reported? 2 1 1 1 2
7) Participant blinding reported? N/A N/A N/A N/A N/A
8) Outcome measure well-defined/robust to  
measurement/misclassification bias?
1 1 1 1 1
9) Sample size appropriate? 0 1 1 0 1
10) Analysis described & appropriate 2 2 2 2 2
11) Estimate of variance reported for main results? 2 2 2 2 1
12) Controlled for confounding? 2 2 1 2 1
13) Results reported in sufficient detail? 2 2 2 2 2
14) Results support conclusions? 2 2 2 2 2
Total score 18 22 21 21 22
Sum score 0.83 0.85 0.81 0.81 0.85
Yes=2; Partial=1; No=0
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at 12 weeks post-treatment: d=0.83 (CI 95% 0.20 
to 1.45). Wozney et al (2017) conducted a mixed 
effects regression on BDI score and reported a time 
by treatment interaction at six months (B=- 0.99, 
t=1.885, p=0.064) but the effect was not as large at 
12 months (B=- 0.44, t=1.52, p=0.133) suggesting 
that a reduction in BDI-II scores could be temporary 
and there is a potential risk of depressive symptom 
relapse.
The Edinburgh Postnatal Depression 
Scale (EPDS) was administered in 
four studies with one study (Kim et 
al 2014) reporting a large significant 
effect size (d=2.08 95% CI 1.05- 
2.97), another (Forsell et al 2017) a 
non-significant medium effect (g=0.52, 
95% CI, - 1.08 – 2.12) and Pugh et al 
(2016) finding no effect for condition 
on EPDS scores. However, in the study 
by Pugh et al (2016) a chi-squared 
analysis approached significance 
(p=0.08) on participants’ classification 
of improved or recovered following 
the intervention based on reduction 
of EPDS scores. Participants in the 
intervention group were found to be 
20 per cent improved and 62 per cent 
recovered in the interventions group. 
In the WLC group, 38 per cent of 
participants were classed as recovered 
and over 50 per cent exhibited no 
change. A regression analysis on time 
by interaction for EPDS scores resulted 
in non-significant reductions.
Depression ratings from the 
Depression Stress and Anxiety Scale 
Short-form (DASS21) were reported 
by Pugh et al (2016) using a multiple 
regression analysis which found the 
intervention lowered depression levels 
B=-0.25, d=-0.90 (-1.54, -0.26).
In addition to depression, four out 
of the five studies assessed anxiety 
as a secondary outcome (Kim et al 
2014, Milgrom et al 2016, Pugh et 
al 2016, Forsell et al 2017). Three 
different anxiety scales were reported: 
Generalised Anxiety Disorder Scale 
(GAD-7), the Beck Anxiety Inventory 
(BAI) and the DASS anxiety. Three 
of the studies reported a reduction 
in anxiety symptoms ranging from a 
small to large effect, however, results 
were predominately non-significant 
(3/4); Kim et al (2014) reported a 
significant reduction in BAI score 
(d=0.5 CI-0.32, 1.28); Milgrom et 
al (2016) reported a non-significant 
reduction in between group scores on 
the DASS anxiety at 12 weeks (d=0.27, 
-0.33, 0.87); Forsell et al (2017) 
assessed anxiety using the GAD-7 and reported non-
significant between group reductions (g=0.63 CI -0.84, 
2.10) but significant within group reductions (g=0.93 
CI 0.05, 1.81). Pugh et al (2016) conducted regression 
analysis on the DASS anxiety and stress scales between 
groups and found non-significant reduction in anxiety 
(B=-20) and a significant reduction in stress (B=-0.41). 
Milgrom et al (2016) also reported on the reduction of 
stress using the DASS and found a significant medium 
Study Outcome measure Effect size CI lower CI upper
Pugh et al (2016) DASS-S -0.98 -1.62 -0.33
Milgrom et al (2016 DASS-S 0.53 -0.08 1.14
Total stress -0.23 -0.85 0.41
Pugh et al (2016) DASS-A 0.23 -0.85 0.38
Milgrom et al (2016) DASS-A 0.27 -0.33 0.87
Forsell et al (2017) GAD-7 0.54 0.1 1.18
Total anxiety 0.35 -0.36 0.81
Forsell et al (2017) EPDS 0.33 0.3 0.96
Pugh et al (2016) EPDS 0.19 -0.43 0.81
Milgrom et al (2016) BDI 0.83 0.2 1.45
Pugh et al (2016) DASS-D -0.9 -1.54 -0.26
Forsell et al (2017) MADRS-S 1.26 0.57 1.95
Wozney et al (2017) SCID 0.51 0 0.72
Milgrom et al (2016) SCID 1.12 0.44 1.81
Total depression 0.48 -0.07 1.06
Abbreviations
BDI: Beck Depression Inventory; DASS-S: Depression Anxiety Scale Short-
form (stress); DASS-A: Depression Anxiety Scale Short-form (anxiety) DASS-D: 
Depression Anxiety Scale Short-form (depression); EPDS: Edinburgh Postnatal 
Depression Scale; GAD-7: Generalised Anxiety Disorder scale; MADRS-S: 
Montgomery-Åsberg Depression Rating Scale- Self report version; SCID: The 
Structured Clinical Interview for DSM-IV/ DSM-V.
Figure 2. Between group forest plot for mental health outcomes.
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effect between groups at 12 weeks (d=0.53 95% CI,  
- 0.08 – 1.14).
Treatment engagement and adherence
Participant engagement and adherence varied due 
to differences in study design, however, overall the 
studies reported moderate to high engagement with 
the interventions.
Kim et al (2014) reported participants 
spent a mean average of 215.8 
minutes on the ‘Good Days Ahead’ 
computer programme over the eight 
sessions and attended a mean of 7.2 
in-person sessions.
Milgrom et al (2016) reported that 
86 per cent of participants completed 
all sessions; the total time spent 
online averaged 370 minutes with 
participants completing a mean of 4.3 
coaching calls out of a possible six.
Pugh et al (2016) reported 60 per 
cent completion of all seven possible 
modules in the intervention with the 
mean number of modules completed 
recorded as 5.92. Additionally, they 
reported high engagement with 
the website with the mean number 
of visits reported as 26.88, mean 
number of client emails sent reported 
as 5.4 and mean number of client 
emails received was 10.52 throughout 
the seven modules.
In the study by Forsell et al (2017) 
the researchers considered those 
participants that completed six out 
of the 10 modules as completers. 
They suggest this is because the 
first six modules contain the main 
components of CBT for depression. 
Therefore, they reported 82 per cent 
of participants as having completed 
six or more modules.
Finally, the study by Wozney et al 
(2017) reported that 22 intervention 
participants completed the full 12 
coaching sessions and the mean 
average number of sessions over all 
the intervention participants was 
9.13 sessions. The mean duration of 
coaching calls in the intervention was 
36.74 minutes.
Discussion
The focus of this systematic review 
was to investigate the effectiveness 
of O-P-T for women with a clinical 
diagnosis of a PMH disorder. To 
the authors’ knowledge it is the first 
to investigate online interventions 
specifically in this population. Five studies were 
included from a total of 2567 identified through 
systematic searches and included a total sample size 
of 209. 
The interventions identified were found to have high 
heterogeneity in their design and varied in their focus 
Study Outcome measure Effect size CI lower CI upper
Milgrom et al (2016) DASS-S 1.07 0.43 1.72
Pugh et al (2016) DASS-S 1.02 0.36 1.68
Total stress 1.05 0.40 1.70
Kim et al (2014) BAI 0.50 0.32 1.28
Forsell et al (2017 GAD-7 1.02 0.39 1.65
Milgrom et al (2016) DASS-A 0.76 0.14 1.39
Pugh et al (2016) DASS-A 0.94 0.28 1.58
Total anxiety 0.81 0.28 1.48
Pugh et al (2016) DASS-D 1.54 0.83 2.26
Forsell et al (2017) MADRS-S 2.01 1.28 2.75
Forsell et l (2017) EPDS 0.88 0.26 1.51
Pugh et al (2016) EPDS 2.76 1.88 3.64
Kim et al (2014) EPDS 2.08 1.05 2.97
Milgrom et al (2016) BDI 1.11 0.46 1.76
Kim et al (2014) BDI 2.47 1.37 3.42
Kim et al (2014) HRDS 2.38 1.30 3.31
Total depression 1.90 1.05 2.70
Abbreviations
BAI: Beck Anxiety Inventory; BDI: Beck Depression Inventory; DASS-S: 
Depression Anxiety Scale Short-form (stress); DASS-A: Depression Anxiety 
Scale Short-form (anxiety)  DASS-D: Depression Anxiety Scale Short-form 
(depression); EPDS: Edinburgh Postnatal Depression Scale; GAD-7: Generalised 
Anxiety Disorder scale; HDRS: Hamilton Depression rating scale; MADRS-S: 
Montgomery-Åsberg Depression Rating Scale- Self report version.
Figure 3. Within group forest plot for mental health outcomes.
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on women in the antenatal and postnatal periods. 
The studies explored the efficacy of the intervention 
with a number of mental health outcomes; however, 
the primary outcome of each study was depression. 
Despite the heterogeneity in intervention design, 
the results of this review suggest that O-P-T for the 
treatment of women classified as having a PMH 
disorder is clinically effective.
Evidence for this can be found in the overview of 
results as they demonstrate that, for the reduction 
of depressive symptomatology, and in some cases 
remission of depressive diagnosis, psychotherapy 
delivered online provided positive between-group 
treatment effects. It can be seen from the included 
forest plots that each of the diagnostic mental health 
scales were found to favour the intervention.
This is important as it builds upon the findings of 
the previous systematic review by Ashford et al 
(2016) who found depressive symptomatology to be 
reduced. However, they noted that the use of self-
report measures made it unclear as to whether similar 
results would be found in women with diagnosed 
mental health issues. This review provides evidence 
for the effective reduction of clinical diagnostic 
symptomatology in women with perinatal depression.
In addition to depression, the review also highlighted 
the potential of O-P-T to be effective in the treatment 
of other PMH symptoms, such as anxiety and 
stress. The results were mixed in terms of statistical 
significance; however, overall treatment effects 
favoured the intervention, with only the study by 
Pugh et al (2016) found to elicit between-group 
outcome measures favouring the control.
Within-group data also provided a strong case for 
the efficacy of O-P-T with all outcomes favouring 
the intervention. Unfortunately, as the authors were 
unable to get the required data to complete within-
group analysis on the results from the SCID outcome 
measures in Milgrom et al (2017) and Wozney et al 
(2017) they were not included in the forest plot. It 
is, however, posited that they would have elicited a 
favourable response toward the intervention based  
on the reported remission statistics.
Study quality
Quality assessment found the studies to have high 
quality ratings, however, there were notable drawbacks 
in a number of areas. Three studies (Milgrom et 
al 2016, Pugh et al 2016, Forsell et al 2017) were 
found to be inadequate in their sampling methods as 
they relied on self-referrals only which was deemed 
high risk for self-referral bias. In contrast, two of the 
studies (Kim et al 2014, Wozney et al 2017) included 
professional referrals though health care providers, 
thereby reducing the risk of bias.
Of the five studies, three reported that blinding of 
investigators was not possible due to the nature 
of psychotherapy (Milgrom et al 2016, Pugh et al 
2016, Forsell et al 2017). However, the two studies 
conducted by Kim et al (2014) and Wozney et al 
(2017) reduced the risk of bias through the blinding 
of evaluators/independent assessment assistants.
All studies were found to have inadequate sample 
sizes which impacts on the ability to generalise the 
findings. This is of particular relevance to those 
studies which completed regression analysis. It is 
suggested that regression analysis requires a sample 
size of n=50 + (8 x number of variables) (Tabachnick 
& Fidell 2013) therefore, as both Pugh et al (2016) 
and Wozney et al (2017) had sample sizes below 
n=50, the results of their regression cannot be 
considered generalisable.
An equally significant aspect was the use of validated 
self-report scales in all the studies; although their use 
is commonplace in research it can leave the findings 
open to self-report bias and an under- or over-
estimation of symptoms (Gorber & Tremblay 2016). 
Despite this criticism, two of the studies (Milgrom et 
al 2016, Wozney et al 2017) also measured clinical 
diagnosis outcome pre- and post-intervention using 
the clinician-administered SCID which provides a 
more robust form of measurement; therefore findings 
can be more readily accepted.
Study design
Of particular salience is the heterogeneity of study 
design. Three out of four of the RCT studies used 
a variation of treatment as usual, however, Pugh 
et al (2016) utilised a waitlist control design as a 
comparator. It has been suggested that the use of 
a waitlist control can overinflate the estimate of 
the intervention effect. Cunningham et al (2013) 
postulate that stalling participants in a ‘non-action’ 
state, whereby they do not attempt behaviour 
change or seek alternative help while waiting for 
the intervention, could elicit less improvement than 
if a control group had been used. Interestingly, the 
opposite can be seen in the study by Pugh et al 
(2016), who noted that WLC participants reported 
seeking regular contact with a family physician 
in almost 58 per cent of cases; 32 per cent sought 
psychotherapy and 25 per cent used psychotropic 
medication. 
Research looking at help-seeking in the perinatal 
period has often found women to be less likely to 
seek help due to barriers such as perceived stigma or 
the lack of identifying PMH problems (Button et al 
2017), therefore it is postulated that the screening 
procedure which involved a diagnostic outcome 
facilitated the removal of such barriers and provided 
opportunity for treatment. The impact of TAU group 
participants’ engagement of outside sources of help is 
also of salience. Milgrom et al (2016) noted that 81 
per cent of participants in the TAU group reported 
using one or more sources of outside support. Only 
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one intervention group participant (5%) reported 
the use of antidepressant medication whilst involved 
in the trial compared to four (19%) in the TAU. 
Similarly, Forsell et al (2017) reported that eight 
women in each study arm had begun counselling 
or psychological treatment during the course of 
the study. Consequently, this may have limited the 
detection of true treatment effects and should be 
considered when interpreting results.
Another important aspect to consider is the length 
of follow up; only one study (Wozney et al 2017) 
analysed treatment effects beyond three months. 
Their results found a significant treatment effect 
with treatment group participants 5.2 times more 
likely to experience diagnostic remission at 12 
months compared to 1.2 times at three months. This 
suggests that designs which include a longer follow 
up period could identify larger treatment effects. This 
supports previous research which has found that the 
probability of recovering from PND increases by 
more than 50 per cent between six and 12 months 
(Torres et al 2019).
When considering the timescale for remission it is 
reasonable to look at other biological factors which 
may impact on treatment response in the perinatal 
period. Due to low oestrogen levels it has been 
suggested that there may be resistance to treatment 
for PND (Robakis & Williams 2013). Additionally, 
there is emerging evidence of the association between 
maternal nutrient depletion and increased risk of 
PMH issues. The use of prebiotics as a mediator to 
enhance the maternal microbiome is suggested to be a 
way to support maternal mental health by way of the 
hypothalamic-pituitary-adrenal (HPA) axis (Rackers 
et al 2018). When added to the associated demands 
of motherhood such as extreme fatigue, possible 
recovery following caesarean section and the care of 
existing children it is not unreasonable to expect a 
delay in recovery. In the study by Pugh et al (2016) 
between-group analysis was only assessed at four 
weeks post-intervention, therefore the suggestion  
of a recovery delay may account for the impact on 
their results.
Attrition rates
A notable finding was that attrition rates ranged 
from low to moderate (five per cent to 40 per cent), 
depending on the length of follow up and the design of 
the intervention. This variation suggests that, although 
the interventions are deemed effective in terms of 
clinical outcomes, the perceived acceptability for 
participants may vary between the intervention design 
with the lowest attrition found in the studies which 
adopted an RCT design and TAU control (Milgrom 
et al 2016, Forsell et al 2017, Wozney et al 2017). 
Previous systematic reviews which investigate various 
online modalities in other mental health populations 
have also found varied attrition rates ranging from 
0 per cent–92 per cent (Bee et al 2008, Berryhill et 
al 2019, Bennett et al 2020). This emphasises the 
importance of intervention design and suggests that a 
PMH population has a similar treatment engagement 
with O-P-T as other mental health populations.
Treatment fidelity and demographics
An important aspect to consider when looking at 
psychological interventions is treatment fidelity. As 
all the online interventions were computer-based 
modules, the fidelity of the CBT treatment was more 
transparent for four out of five of the studies which 
provided detailed information on the module content 
and clinician involvement (Kim et al 2014, Milgrom 
et al 2016, Forsell et al 2017, Wozney et al 2017). 
However, it is noted that treatment fidelity was not 
assessed and reported in the studies and this can have 
a negative impact (Waltman et al 2017).
A pertinent point to note regarding the demographic 
information included in the studies was the lack 
of reporting on breastfeeding status, with just one 
study reporting it in between-group participant 
characteristics (Pugh et al 2016). Breastfeeding has 
been found to reduce the severity of PND and anxiety 
as increased prolactin levels during breastfeeding 
regulate the stress response and modulate anxiety and 
depressive-like behaviours (Kendall-Tackett 2007). 
Conversely, poor breastfeeding experiences and short 
breastfeeding duration are associated with higher 
depression scores (Brown et al 2016). This is not only 
pertinent for studies which look at postnatal disorders 
but, as some women breastfeed previous children 
throughout pregnancy, it is relevant for studies 
focusing on AD.
Implications for future research
This review highlights a gap in the literature for 
research which explores the use of a wide range 
of therapeutic approaches using online modalities. 
Despite a plethora of research exploring the use 
of eye movement desensitisation and reprocessing 
therapy (EMDR) for depression there were no studies 
which addressed this area. Current NICE guidelines 
(CG192, section 1.9.5) state that CBT and EMDR are 
the only approved therapies for PTSD in the perinatal 
period (NICE 2014).
Additionally, with the impact of the restrictions on 
F2F therapy due to the global COVID-19 pandemic it 
is pertinent to consider research into different online 
modalities, such as videoconferencing, to enable 
women to gain access to a range of treatments from 
home. Furthermore, it was evident from the small 
number of included studies, that there is a need for 
further research into O-P-T for other diagnosed PMH 
disorders beyond depression. Indeed, there is the 
lack of studies which look at online interventions for 
women diagnosed with PTSD following childbirth, 
perinatal OCD, perinatal psychosis and tokophobia.
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Strengths and limitations
There are a number of notable strengths of the 
current review. It adopted a clear search strategy and 
inclusion criteria which followed PRISMA guidelines 
and included dissertations and theses. Study eligibility 
and inclusion were assessed by five of the authors 
to ensure methodological rigour and minimise bias. 
Moreover, study quality was assessed individually and 
subsequently discussed as a group to ensure agreement.
It is, however, important to note the limitations of 
this review. As the number of included studies was 
small, and high in heterogeneity of intervention design, 
it was not possible to complete a full meta-analysis 
with findings hard to synthesise. The small number of 
included studies and their small sample sizes limited 
the strength of evidence of this review. 
In addition, it is important to consider the impact of 
publication bias. It is often the case that studies which 
produce non-significant results are less likely to be 
published leading to an over-inflation of the review’s 
positive outcomes (Lefebvre et al 2019). Additionally, 
as resources were not available to translate non-English 
papers the review could be subject to language bias 
and the possibility of studies not included, which may 
reduce the ability to generalise the results (Lefebvre et 
al 2019). However, evidence has suggested that for the 
majority of systematic reviews the exclusion of non-
English language studies has not affected the review 
conclusions (Morrison et al 2012, Hartling et al 2017).
Conclusion
This systematic review has demonstrated that O-P-T 
interventions for the treatment of PMH disorders 
are effective in the reduction of mental health 
symptomatology and in some cases may result in 
the remission of depressive diagnosis. Findings also 
suggest perinatal populations are likely to engage 
well with online treatment modalities. More research 
is required for interventions that not only assess 
different therapeutic approaches such as EMDR but 
also different online modalities for a broader range of 
PMH disorders.
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Background: The use of existing clinical/administrative Big Data (BD) when conducting 
research has become common. In the absence of a single comprehensive source of data, 
data linkage of multiple sources has proved to be of value in midwifery and public  
health research.
Aim: The purpose of this paper is to describe the process of accessing BD, linking sources 
and validating the outcomes to answer specific public health questions.
Method: This article describes and discusses the experience and challenges of using 
BD whilst undertaking a study to answer the research question: ‘What is the prevalence 
and risk factors of congenital heart defect (CHD) in Northern Ireland (NI)?’ Data from the 
Northern Ireland Maternity System (NIMATS) (2010–2014), Enhanced Prescribing Database 
(EPD) (2010–2014), and the HeartSuite database (HSD) (2005–2014) were accessed, linked 
and analysed using Stata version 13.
Ethical approval: Ethical approval was obtained from the National Health Service (NHS) 
Research Ethics Committee (REC) (No. 17/SC/0103, 27 February 2017). Permission to 
access data was obtained from the Honest Broker Service (HBS) acting as a safe haven 
for the conduct of BD research. Training in the use of the HBS was undertaken to ensure 
confidentiality, anonymity and data protection. There was a fee to be paid to HBS to cover 
data preparation cost.
Findings: Successfully linking routinely collected BD sets from multiple sources (HSD, 
NIMATS, EPD) facilitates the creation of a robust and more complete data set, from which 
conclusions can be drawn, than may previously have been possible. The experience of 
working in the HBS was a huge learning curve in acquiring an in-depth understanding of 
the data extraction process, data verification and data analysis.
Conclusions and implications: Data anonymisation and controlling access to the data are 
important as they enable ethical access of clinical/administrative BD. The quality of the data 
was variable in the databases but the linkage process enhanced the value of the outputs. 
Research of this type has value for midwives, other healthcare practitioners and policy 
makers in public health settings as it provides factual data that can impact public health. 
However, as in all types of research, using and linking clinical/administrative BD for public 
health research has its strengths and limitations which should always be acknowledged.
Keywords: big data, clinical data, administrative data, public health research, Evidence 
Based midwifery, Northern Ireland Maternity System, Enhanced Prescribing Database, 
HeartSuite database, Honest Broker Service
Introduction
There is growing awareness of the significant potential 
for researchers to maximise the use of clinical and 
administrative data. Habl et al (2016) provided 
recommendations about how to improve population 
well-being by utilising the opportunities provided by 
Big Data (BD) for public health. Recommendations 
included urgent need for raising awareness of the 
importance and possibilities of using BD in public 
health quality improvement (Habl et al 2016).
BD can enable the establishment of a population 
surveillance system, which can assist policy makers 
to identify health policy issues, improvements and 
impact (Kemm et al 2010). BD is used to discover 
risk factors and association between risk factors and 
outcome (Riley et al 2013). It can also be used in 
ABSTRACT
19The Royal College of Midwives, Evidence Based Midwifery 19(1): 19-31
Saad H, Bunting B P, McCullough J EM (2021). How can Big Data be used to answer public health research questions?.  
Evidence Based Midwifery 19(1): 19-31
predicting health outcomes (Maragatham & Devi 
2019), rare disease presentation (Moore et al 2014), 
and adverse events after surgery (Humes et al 2013). 
BD can be used to identify the sensitivity of diagnostic 
methods (Borgquist et al 2014) and the underlying 
cause of death (Hassanzadeh et al 2017).
The study data refer to the clinical and administrative 
records of all pregnant women in NI, known as 
NIMATS, the general practitioner (GP) prescribing 
data, known as EPD, and the HSD which holds 
records of all diagnosed cases of congenital heart 
defect (CHD) in NI.
The concept of clinical, administrative databases 
and health-related BD
Data used in health research can be clinical or 
administrative or both. Administrative data 
include diagnostic codes or International Statistical 
Classification of Diseases and Related Health 
Problems (ICD) codes, mortality, claims, and 
demographic data (Ambroggio & Shah 2013). Data 
such as vital signs, medical or surgical history are 
regarded as clinical data (Raghupathi & Raghupathi 
2014). However, data can also be a mix of clinical 
and administrative data, as was the case in this study.
A database is defined as ‘a collection of organised, 
related data, especially one in electronic form that can 
be accessed and manipulated by specialized computer 
software’ (Random House Kernerman Webster’s 
College Dictionary 2010). The term BD in health 
has been defined as ‘large routinely or automatically 
collected datasets, which are electronically captured 
and stored. It is reusable in the sense of multipurpose 
data and comprises the fusion and connection of 
existing databases for the purpose of improving 
health and health system performance. It does not 
refer to data collected for a specific study’ (Habl  
et al 2016).
Process of making data accessible in Honest 
Broker Service
Honest Broker Service (HBS), which was founded 
by Business Services Organisation (http://www.
hscbusiness.hscni.net/index.htm), enables non-
identifiable data to be safely shared and accessed  
in order to expand data utilisation and the related 
health service benefits which can be attained by  
using these data.
Early communication
For any study that requires clinical/administrative 
BD from the data custodian (HBS in this study), early 
communication is necessary between the researcher 
and data custodian in order to explain the project, 
discuss the feasibility of the study protocol, and agree 
subsequent steps. Ongoing clarification of issues 
related to the variables was necessary in this study as 
there was no available standard for variable format, 
definition, or quality and completeness.
A database transfer plan was needed as the HSD was 
not available in the regional data warehouse. HBS 
agreed to load a temporary file from HSD into their 
data warehouse, pending Data Access Agreements, 
NHS REC approval, and Honest Broker Governance 
Board (HBGB) approval. These issues had to be taken 
into consideration before applying for ethical and 
governance approval to begin the study.
Ethical and governance consideration
To adequately address ethical and governance issues, 
Data Access Agreements with Belfast Health and 
Social Care Trust were signed by HBS and Ulster 
University (UU) as required by the Department of 
Health and in accordance with the Health and Social 
Care (HSC) protocol for sharing service information 
for secondary purposes.
Analysis was undertaken in a safe setting in HBS, a 
research access agreement and a disclosure policy 
agreement were signed, obliging the researcher not to 
attempt to identify individuals. The agreement also 
stated the principles to be followed when disclosing 
and using service user information, encapsulated in 
the Code of Practice and Good Practice principles, 
Data Protection Act 2018 (DPA 2018) principles 
and Caldicott principles. The researcher completed 
HBS Safe Researcher training. To protect patient 
confidentiality, HBS applied statistical disclosure 
control to all outputs before providing them in an 
anonymised format to the researcher.
Databases used in this study and preparations 
requested to make this study feasible
The databases which were used in this study are 
discussed in the following section, detailing the data 
preparation by HBS and the variables requested for 
the purpose of the study. Prevalence and risk factors 
of CHD in NI was the main research question, which 
required accessing three databases, and the discussion 
of those three databases and the variables related to 
them were based on the main research question.
HeartSuite database (2005–2014)
HeartSuite (HSD) is mainly a clinical database which 
holds records of all diagnosed cases of CHD in 
NI. It is operated and maintained by the Paediatric 
Cardiology Department of Royal Belfast Hospital for 
Sick Children. HSD is a cohesive patient management 
system specifically designed for cardiothoracic surgery 
and paediatric cardiology.
In this complicated field, HSD is an adaptable 
and developing system which provides an online 
electronic medical record while also recording and 
generating information in real time on all phases of 
a patient’s care. The majority of the UK specialist 
paediatric cardiac centres use HSD, which enables 
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comprehensive clinical audit information to be 
gathered (HeartSuite 2015).
The variables from HSD that were requested, and 
details of their completeness, are described in Table 
1 (see Supplementary information). The quality of 
any data is determined by the completeness and 
accuracy of the data (Olsen et al 2010). Most of 
the variables requested attained more than 90 per 
cent completeness. The accuracy of the diagnostic 
variables in HSD is expected to be high, due to the 
high percentage of completeness. When a cardiologist 
makes a diagnosis, that information can be 
automatically inserted into HSD by selecting the code 
corresponding to the disease from a drop-down menu, 
thereby streamlining the data capture process. The 
ease of this process is important, because the accuracy 
of certain information in clinical data sets diminishes 
as the actions required to transfer that data into the 
data set become more complex (van Walraven & 
Austin 2012).
Four tables (echo results, diagnoses and comorbidity, 
cause of death and procedures) were extracted from 
HSD, transferred to HBS, and merged together to 
create a single table with one row per case, using the 
patient’s unique health and care number (HCN), case 
note, or date of birth.
Data preparation by HBS for HSD
Notes for file preparation were given to HBS 
explaining how to merge the data into a single file for 
analysis. The notes stated that the echo results table 
(n=34,092 records), diagnoses and comorbidity table 
(n=16,422 records), the cause of death table (n=189 
records), and the procedures table (n=893 records) 
should be formatted so that one row is given per case.
The echo results table was used to deal with 
duplicates (where values of variables differ) and to 
identify the date of first diagnosis (n=34,092 records; 
as there were multiple rows per case and for each 
CHD case, the first entry date was taken for inclusion 
in the study file and all other entries deleted). For the 
echo results table, taking the date of the earliest echo 
for each identity document (ID) reduced the number 
of rows from 34,092 to 11,425. Of 11,413 rows, 
8,378 (73 per cent) in the diagnosis and comorbidity 
table linked successfully to the echo table.
As the date of the first echo is used with date of birth 
to calculate the age at diagnosis, the fact that 27 per 
cent of patients in the diagnosis and comorbidity table 
did not have an echo date was problematic. Rather 
than have approximately 3000 null ages, the date of 
first echo was used where available, and earliest date 
of diagnosis, from the diagnosis and comorbidity table, 
was used when there was no echo date. Consequently, 
all patients have a value for age at diagnosis.
For the diagnoses and comorbidity table, the 
duplicate diagnoses were appended as additional 
variables to the relevant rows, that is, European 
Paediatric Cardiac Code (EPC)1 2, EPC2 2, ICD9 2 
and ICD10 2 relate to that patient’s second diagnosis 
entry. Each patient could have up to nine diagnosis 
entries, although most had only one.
For the cause of death table, of 188 rows, 145 
rows (77 per cent) were joined to the diagnosis and 
comorbidity table and the date of death was blank in 
12 of these rows.
Once the four tables were combined, non-NI postcode 
cases were excluded on the assumption that those 
cases were not NI residents. The final output merged 
file contains 11,410 rows and had one patient per 
row. Postcodes were available for 8638 of the 11,410 
patients (76 per cent). This allowed urban/rural 
status and deprivation quintile to be assigned using 
the latest urban rural classification (2015) (Northern 
Ireland Statistics & Research Agency 2016). For 
a small number of patients (<10), a postcode was 
available but was invalid.
Northern Ireland Maternity System (2010–2014)
Northern Ireland Maternity System (NIMATS) is an 
electronic clinical database used by HSC Trusts to 
record details of women seeking maternity care in NI. 
It includes details of current and any past pregnancies 
and records whether a woman gave birth to a live-
born or stillborn baby. Midwives are the first point of 
contact for pregnant women and maternity care is led 
by midwives for all non-complex cases.
The variables from NIMATS that were requested for 
the study are described in Table 2 (see Supplementary 
information), together with the completeness of each 
variable. Only records of resident pregnant women 
were extracted for use in the current study. Some 
variables showed a very low level of completeness 
and thus were not used in the analysis, for example 
MOTHER_FOLIC_ACID (10 per cent completeness). 
However, this variable was incomplete as it was only 
available for part of the time period covered by this 
study. Fully complete folic acid variables are available 
from 2014/15 onwards.
The purpose of NIMATS is to follow the woman 
during the antenatal period, hence it is expected to 
have a high degree of accuracy especially with regard 
to variables such as the woman’s age, body mass 
index (BMI), previous family history of chromosomal 
abnormalities and CHD. Midwives input the required 
details into the system during interviews and most of 
the variables are for special concerns regarding case 
management and advice provided.
The variables requested in this study were not 
available in a single table, therefore, NIMATS data 
were extracted by HBS into eight tables. These tables 
were then joined together by HBS to create one table 
containing all the variables. The tables were joined 
using the HCN of the pregnant woman (MOTHER_
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HCN) and the booking interview date (DATE_OF_
BOOKING_INTERVIEW). Together, these two 
variables uniquely identified a pregnancy.
The data contained 119,165 rows. The NIMATS 
tables often contained more than one row for a 
pregnancy when that pregnancy had different 
values for a given variable. For example, if the 
woman had more than one medication, each 
medication was recorded in a separate row. In 
order to provide a single table with one row per 
pregnancy where possible, HBS recoded values 
into additional variables, for example, MOTHER_
PRES_MEDICATION_1 to MOTHER_PRES_
MEDICATION_8, containing the (up to) eight 
different values present for each pregnancy in the 
Present Medications table.
Data preparation by HBS for NIMATS
HBS agreed to take specific steps before making the 
file ready for analysis. Each row related to a different 
birth. For multiple pregnancies only the baby with 
CHD was included; only the most recent pregnancy 
was included except where a woman had more than 
one pregnancy with a baby with CHD, in which 
case all pregnancies were included, and except in the 
case of multiple births, where all were included. The 
STUDY_ID variable (number of all births) was a case 
number from 1 to 96,233, while the MOTHER_ID 
variable (number of mothers) was a case number 
from 1 to 94,545. Multiple births were distinguished 
by the BIRTH_NUMBER variable. After removing 
multiple pregnancies not involving more than one 
case of CHD, 96,321 rows remained. Removing 88 
rows due to non-NI postcodes produced the final 
NIMATS dataset containing 96,233 rows, including 
1204 with blank postcodes. A valid urban/rural status 
was assigned to 94,930 rows (99 per cent of all rows) 
and a valid deprivation status was assigned to 95,000 
rows (99 per cent of all rows).
Enhanced Prescribing Database (2010–2014)
Enhanced Prescribing Database (EPD) includes 
information on all drugs that have been prescribed 
by GPs and redeemed by patients in NI. However, 
patient information is only available for prescriptions 
that can be scanned electronically, which may reduce 
the number of records available. EPD was created to 
facilitate payment to pharmacies. Although designed 
for budget management, payment databases have 
been widely used in health services research (Marrie 
et al 2017), and EPD has been used in previous 
studies (Wemakor et al 2014).
The list of variables requested from EPD for the 
current study are listed in Table 3 (see Supplementary 
information). Some of the variables were used to 
create the specific variable which included the specific 
medications needed to perform this study. Based on 
British National Formulary (BNF) classifications, the 
medications were grouped into four main groups: 
mental health medications (MHM), folic acid and 
vitamins, folic acid antagonist medications and 
medications for case exclusion.
In the EPD file there were 182 different types of 
MHM; this number included different doses and 
different brand names for the same medication. 
These were collapsed into 49 specific medications by 
grouping brand names and different doses of the same 
medications.
General Data Protection Regulation and Data 
Protection Act
The implementation, in May 2018, of the General 
Data Protection Regulation (GDPR) (Regulation 
EU 2016/679 of the European Parliament and of 
the Council 2016) in the UK was based on the DPA 
(Department for Digital, Culture and Sport and the 
Home Office 2018). The GDPR and the DPA have an 
impact on how researchers deal with BD in research.
The changes introduced by the GDPR make it clear 
that anonymised data are no longer regarded as 
personal data (GDPR 2018, Information Compliance 
Team 2018, The British Psychological Society 2018). 
The GDPR also highlighted that: ‘The principles 
of data protection should therefore not apply to 
anonymous information’ (GDPR Recitals 2018:26).
These changes highlighted that the utmost effort 
is required to keep data anonymous. To this end, 
regulations included in the DPA (2018) state that: 
‘it is a criminal offence in cases where anyone uses 
anonymised data knowingly or recklessly to re-
identify information that is de-identified personal 
data’ without data custodian consent (DPA 2018:99).
The researcher and data custodian should make 
every effort to keep data anonymous. In this study, 
this involved training courses for researchers 
which outlined these concepts and highlighted the 
importance of maintaining anonymity of data. Data 
should not be kept longer than is necessary, this 
was specified in the HBS application form before 
obtaining access to the data. Data were accessed 
only in the HBS safe haven. Where less than 10 cases 
for a particular variable were retrieved, or where 
there was any risk of identification of an individual, 
HBS withheld these cases in accordance with their 
disclosure control procedure.
GDPR clarifies the legal basis for processing data, 
which should be because doing so is ‘in the public 
interest’. This means that studies must clearly set 
out the public interest which will be served through 
accessing required data. The purpose of future 
studies is to attempt to guide public health action 
for prevention and service planning, therefore 
accessing data is legal for studies in the public interest 
(Information Compliance Team 2018).
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Data validation and verification
Some of the key issues that arose in relation to 
using available clinical/administrative BD were 
related to validity of the data, and this has two 
aspects: accuracy and completeness. The accuracy 
of data entry, their selection and quality, and 
collection methods were not under the control of 
the researcher and were sometimes impossible to 
validate. In databases used in this study, standard 
definitions for each variable were not available, and 
data entry practices used by health providers was 
not standardised for some variables. Use of non-
standardised texts made some variables difficult to 
understand and to analyse, as the text used depended 
on the personal preference of the data inputter.
For HSD, values were acceptable for most of the 
variables, however there were a small number 
of variables which could not be analysed. For 
example, values for the age at diagnosis (AGE_AT_
DIAGNOSIS_YEARS) turned out to be negative in 13 
cases and meant that those cases were not included 
in analysis for that specific variable. Another example 
was the fetal diagnosis (FETAL_DIAGNOSIS) 
variable which took values of 1, N, U, Y, or blank 
which did not give a clear idea whether a child had a 
fetal diagnosis or not (see Table 1).
In this study, and in HSD, the CHD diagnosis was 
the main outcome and measured by using ICD and 
EPC codes. Both codes were presumed to be reliable 
and accurate as they are used to facilitate individual 
clinical management. It is important to note, however, 
that HSD used EPCC definitions in addition to ICD 
codes. ICD codes, produced by the World Health 
Organization (WHO 2016), have been used in health 
research for studying disease pattern, patterns of care 
and outcomes of disease. ICD9 and ICD10 codes, 
although used all over the world, have limitations and 
are increasingly viewed by paediatric cardiologists as 
insufficient for depicting CHD (Houyel et al 2011). 
Hence, additional clinical information related to CHD 
which may be useful for more clinically oriented 
studies can be obtained by using EPCC to cover  
that gap.
In an effort to verify some of the data in this study, 
a comparison of mortality data from the HSD file 
with results from external reports was performed. 
Mortality data from HSD using the variable age at 
death (AGE_AT_DEATH_IN_DAYS) showed that, 
for the period 2005–2014, there were 63 deaths 
among children who were live born with CHD. This 
is less than the figure for infant mortality due to 
CHD for the same period (78 deaths) sourced from 
the Northern Ireland Statistics and Research Agency 
(NISRA) website, which provides statistics on vital 
events registered by the General Registrar Office for 
NI. The information from NISRA is considered to be 
of high quality and regarded as a source of research 
data in NI (https://www.nisra.gov.uk/), therefore 
suggesting that this variable is not complete in HSD.
Other examples of lower quality variables in 
HSD include the cause of death variable (CAUSE_
OF_DEATH) which was written as free text and 
very sparsely populated, presence of comorbidity 
(COMORBIDITY_PRESENT) and rating of the 
catheterisation (CATHETERISATION_RATING) 
which also showed blank values for all the 
data. There is, therefore, room for data quality 
improvement.
For NIMATS, the values were acceptable for most 
of the variables, however, again there were a small 
number of variables which had issues related to the 
range of acceptable values. For example, values for 
the infant gender (INFANT_GENDER) variable had 
a small number of cases with values of 1 and 2 but 
did not specify which was male/female. The variables 
showing whether or not a woman was taking folic 
acid (MOTHER_FOLIC_ACID_1 to MOTHER_
FOLIC_ACID_4) were low quality, with 10 per cent 
or less value completeness (see Table 2). Again, there 
is room for data quality improvement.
In another effort to verify some of the data in this 
study, checks were conducted on the data comparing 
some descriptive results from the NIMATS file with 
results from the Children’s Health in Northern 
Ireland report (Public Health Agency 2016). Six of 
the eight variables from the report showed almost 
the same results from the current data; two variables 
showing a recognisable difference were number of 
live births and stillbirths for years 2010 and 2011. 
This can most likely be attributed to the request in the 
project application for only the most recent delivery 
for women with more than one pregnancy in the time 
period 2010–2014.
It is important to note that, as demonstrated in Tables 
1 and 2, the completeness (coverage) of most of the 
variables in both databases was reasonably good. A 
missing rate of five per cent or less is considered to be 
insignificant (Schafer 1999), however, Bennett (2001) 
stated that when more than 10 per cent of data are 
missing the statistical analysis is likely to be biased. 
For this reason, variables with missing values of more 
than 10 per cent were not used in the study, and 
sensitivity analysis was based on that figure.
Benefits and limitations of using clinical/
administrative BD and linking BD for public 
health research
Using clinical/administrative BD conferred several 
benefits, one of the most important being a very 
low drop-out rate as this type of database covers 
the whole population (Harron et al 2014). When 
recruiting participants for prospective studies, 
bias may result as people with higher educational 
attainment, higher socio-economic status and better 
health are more likely to be recruited than the wider 
population (Nishiwaki et al 2005). When recruiting 
for prospective studies, it is also acknowledged that 
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less healthy individuals are more likely to drop out 
during follow-up (Murphy et al 2011). This can lead 
to biased estimates of association between risk factors 
and outcome, a situation which can be avoided by 
using routinely collected data samples.
The clinical/administrative BD in this study was used 
in a longitudinal cohort study which is considered 
to be of good quality in the hierarchy of evidence 
(Hagger-Johnson 2014). Using the availability of 
existing databases is less time-consuming and more 
cost-effective in comparison to research based on 
primary data. 
As with other BD studies, not all required variables 
were available, but understanding of variables in 
the database was crucial for the researchers to be 
able to create derived variables. For example, age at 
diagnosis was important to measure the prevalence of 
CHD precisely, as prevalence changes based on age at 
diagnosis. Age at diagnosis was not available in HSD 
as a distinctive variable hence the date of the first 
echo was used, along with date of birth, in order to 
calculate the age at diagnosis.
The use of clinical/administrative BD involves large 
samples which is very helpful, especially when 
studying rare diseases such as CHD. Using big health 
data may produce results with significant association. 
However, statistically significant results should 
be discussed cautiously to highlight whether their 
significance is clinical or statistical. To distinguish 
between statistical and clinical significance, absolute 
and relative differences and confidence intervals 
should be used when comparing two different 
populations (van Walraven & Austin 2012).
Linking BD for public health research
Linking clinical/administrative BD has been 
acknowledged to be beneficial for public health 
research and data linkage is a cost-efficient way 
of obtaining information rapidly to guide policy 
(Hagger-Johnson 2016). In this study, which involved 
data covering up to 10 years, it took less than six 
months from the HBGB approval of the study to data 
being accessed. The main research question of the 
study regarding prevalence and risk factors of CHD 
in NI was answered rapidly using linked data for the 
purpose of guiding public health action for prevention 
and service planning, without the need to spend years 
gathering new data.
Linking data to obtain a final data file may improve 
the quality, integrity, and strength of data (Kemm et al 
2010). For example, a variable might be available in a 
data set with poor quality and linking this data with 
another database, which includes the same variable 
with a better quality, improves the final data file. This 
was the case in this study, where there was eight per 
cent missing data on the postcode variable in HSD 
(the postcode was crucial to assign deprivation and 
urban/rural status). However, when using the linked 
file and the variable from NIMATS (covering the 
period 2010–2014), missing data from the postcode 
variable decreased to one per cent and data quality 
improved dramatically. Additionally, as there was a 
unique identifier for each case, data linkage allowed 
identification of duplicates.
Data linkage studies may promote data privacy 
and confidentiality. In this study, the privacy and 
confidentiality of individuals was protected by 
ensuring that personal identifiers, such as names, 
were not available in the linked dataset analysed by 
the researchers. Data access took place in the safe 
haven, the researcher and HBS worked together to 
apply statistical disclosure control for all results 
and numbers less than 10 were not presented in the 
results.
Conducting a data linkage study encourages 
cooperation between different professionals such 
as researchers, clinicians and data providers. 
Communication within the multidisciplinary team 
improved understanding and identification of 
current issues related both to the study and to future 
opportunities (Holman et al 2008). In this study 
professionals agreed that the research questions could 
not be clearly answered without data linkage, and 
that data linkage would make the study more feasible.
Funders from within and outside NI may be more 
likely to finance research which uses linked data from 
NI and therefore has commercial and competitive 
benefits for NI. NI Chest, Heart and Stroke (https://
nichs.org.uk) provided partial funding to cover 
the costs incurred by HBS in creating a linked, 
anonymised dataset, use of the safe setting in which 
to analyse the data, and the time taken for disclosure 
control checks prior to outputs leaving the safe 
setting.
Difficulties and limitations
Linking data has some difficulties and limitations. 
Data linkage studies can be time-consuming (Flowers 
& Ferguson 2010) and a laborious process (Lawrence 
& Bradley 2018). This was the case in this study, not 
in terms of performing the technical linkage, but to 
fully identify and understand all the issues related to 
data sets and the high number of variables (especially 
where no metadata is available for each variable 
required).
In this study different files and variables were linked 
together for the first time. The possibility of failure 
to obtain correct and good quality variables might 
be frustrating to researchers. Dealing with different 
organisations that may have different procedures and 
regulations to gain approval for the research requires 
personal skills such as perseverance, leadership, and 
inter-sectoral cooperation.
Although maintenance of privacy and confidentiality 
of the data has been recognised as a strength of 
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data linkage studies, in this study and the literature 
(Holman et al 2008), some risk of disclosure of 
individual information and other confidentiality 
issues remains (Flowers & Ferguson 2010). In this 
study, disclosure control was applied by HBS and 
the researcher as explained earlier. It is important 
to emphasise that when undertaking research with 
human subjects, tension can arise between the need 
for data protection on one hand and data sharing 
on the other. Corti et al (2014) emphasised that even 
sensitive and confidential research data can be shared 
ethically and legally, as long as certain criteria are 
met. These criteria include anonymising the data and 
controlling access to the data if necessary.
Conclusions
In conclusion, routinely collected clinical/
administrative BD from HSD, NIMATS, and EPD 
that can be linked together are relatively reliable 
and provide important variables that can be used in 
public health research. The variables from different 
databases used in this study were generally of 
good quality, covering the whole population of 
NI. Understanding the variables in databases is 
mandatory to create necessary derived variables. 
The usage of BD allows the study of rare diseases 
and permits sub-groups analysis. It is important 
for midwives and other health care professionals to 
understand the value of their role in BD research 
studies, including the need for clear and accurate 
record taking and data inputting.
Reporting the percentage and completeness of 
variables used in databases has given an idea about 
data quality for potential future research covering 
the period of 2005–2014 and 2010–2014. Clinical/
administrative BD should be checked regularly for 
quality, and quality improvement should be targeted 
continuously to ensure a high standard of data 
that are fit for the purpose of research. Standard 
clarification of what each variable in NIMATS 
means is required to facilitate standard completion 
of patients’ information in the system and to enhance 
the data available for research. Metadata should 
also be established for all clinical data in NI. It is 
important to note that, while there was a lack of 
available metadata for the NIMATS database during 
the period of this research, NIMATS metadata is now 
available.
The research questions posed by this study, which 
were the prevalence of CHD and the association 
between specified risk factors and CHD in NI, were 
answered. The study demonstrated that data linkage 
studies, using different files from various sources 
through the HBS, are feasible to answer public health 
research questions. Data anonymisation and access 
control were important as these enabled ethical access 
of clinical/administrative BD.
To promote transparency in discussions and results, 
strengths and limitations of using and linking clinical/
administrative BD for public health research should 
always be acknowledged. Researchers should be 
prepared to overcome challenges in dealing with these 
databases in order to set up agreed standards for 
variable definitions and qualities and to benefit from 
and share their experiences.
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Supplementary information
Table 1. Description and completeness of variables from HSD used in the study.
Variable Description Completeness of data/comments
1. PREVALENCE_STUDY_ID A case number numbered from 1 to 
11,410.
100%
2. YEAR_OF_BIRTH Based on date of birth. 100%
3. AGE_AT_DEATH_YEARS Calculated from date of birth and date of 
death, where available.
     1%
4. AGE_AT_DIAGNOSIS_YEARS Calculated from date of birth and date 
of earliest echo. Where date of earliest 
echo was not available, earliest date of 
diagnosis (from the diagnosis table) was 
used instead.
100%
5. AGE_AT_PROCEDURE_YEARS [1-5] Calculated from date of birth and 
procedure date. There are up to five 
separate variables for patients who have 
had multiple procedures.
AGE_AT_PROCEDURE_YEARS1    5%       
AGE_AT_PROCEDURE_YEARS2    1%       
AGE_AT_PROCEDURE_YEARS3 <1%      
AGE_AT_PROCEDURE_YEARS4 <1%  
AGE_AT_PROCEDURE_YEARS5 <1%      
6. YEAR_OF_DEATH Based on year of death (in HSD).       1%
7. AGE_AT_DEATH_IN_DAYS Calculated from date of birth and date 
of death, where available. Values include 
‘0-6 days’, ‘7-27 days’, ‘28-364 days’ and 
‘not within first year’.
      1%
8. CAUSE_OF_DEATH Free text. Very sparsely populated.    <1%
9. SEX Takes values ‘M’, ‘F’, ‘U’ or blank. 99.90%
10. FETAL_DIAGNOSIS Takes values ‘1’, ‘N’, ‘U’, ‘Y’ or blank. 20%
11. EPC1 [1-9] European Paediatric Cardiac (EPC) code. 
Each diagnosis record had two EPC 
variables: EPC1 and EPC2. Duplicate 
diagnoses were recoded as additional 
variables and indicated by the second 
digit in the variable name. For example, 
EPC1 3 indicates that a patient has three 
separate entries in the diagnosis table. 
Up to nine rows are available for each 
patient in the HeartSuite diagnosis table.
EPC1 1 100%
EPC1 2   29%
EPC1 3     8%
EPC1 4      3%
EPC1 5      1%
EPC1 6    <1%
EPC1 7   <1%
EPC1 8    <1%
EPC1 9    <1%
12. EPC2 [1-9] These are the second EPC codes for each 
diagnosis record. For example, EPC2 3 
gives the second EPC code value when a 
single patient has three separate entries 
in the diagnosis table.
EPC2     113%
EPC2 2     6%
EPC2 3     2%
EPC2 4      1%
EPC2 5   <1%
EPC2 6   <1%
EPC2 7   <1%
EPC2 8   <1%
EPC2 9   <1%
13. ICD9 [1-9] International Classification of Diseases 
and Related Health Problems (ICD), 
edition 9. See EPC1 for explanation of 
‘[1-9]’.
ICD9 1   74%
ICD9 2    21%
ICD9 3      6%
ICD9 4      3%
ICD9 5      1%
ICD9 6   <1%
ICD9 7    <1%
ICD9 8   <1%
ICD9 9   <1%
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Variable Description Completeness of data/comments
14. ICD10 [1-9] International Classification of Diseases 
and Related Health Problems (ICD), 
edition 10. See EPC1 for explanation of 
‘[1-9]’.
ICD10 1   80%
ICD10 2   27%
ICD10 3     8%
ICD10 4     3%
ICD10 5     1%
ICD10 6   <1%
ICD10 7   <1% 
ICD10 8   <1%
ICD10 9   <1%
15. DIAGNOSIS [1-5] Diagnosis variable from the HeartSuite 
procedures table. Originally coded using 
25 separate variables, linked together 
here to prevent an excessive number of 
variables. Free text, including codes. Up 
to five separate variables are assigned 
to patients who have had multiple 
procedures.
DIAGNOSIS1      5%
DIAGNOSIS2      1%
DIAGNOSIS3   <1%
DIAGNOSIS4   <1%
DIAGNOSIS5   <1%
16. COMORBIDITY_PRESENT Blank values for all cases.       0%
17. COMORBID_CONDITIONS [1-5] Comorbid conditions variable from the 
HeartSuite procedures table. Free text, 
including codes. Up to five separate 
variables are assigned to patients who 
have had multiple procedures.
COMORBID_CONDITIONS 1        1%
COMORBID_CONDITIONS 2      <1%
COMORBID_CONDITIONS 3      <1%
COMORBID_CONDITIONS 4      <1%
COMORBID_CONDITIONS 5      <1%
18. PROC_DATE [1-5] Procedure date variable from the 
HeartSuite procedures table. Up to 
five separate variables are assigned 
to patients who have had multiple 
procedures. The first PROC_DATE variable 
contains the latest procedure.
PROC_DATE1     5%
PROC_DATE2     1%
PROC_DATE3   <1%
PROC_DATE4  <1%
PROC_DATE5  <1%
19. PROC_TYPE [1-5] Procedure type variable from the 
HeartSuite procedures table. Up to 
five separate variables are assigned 
to patients who have had multiple 
procedures. The first PROC_TYPE variable 
contains the latest procedure.
PROC_TYPE1     5%




20. CATHETERISATION_RATING Blank values for all cases.       0%
21. URBAN_RURAL_2015 Urban rural classification based on 
NISRA’s Review of the Statistical 
Classification and Delineation of 
Settlements (March 2015). Assigned from 
patient postcode using the November 
2016 Central Postcode Directory.
      76%
22. NIMDM_2010_QUINTILE Deprivation quintile, from 1 (most 
deprived) to 5 (least deprived).
Calculated from the NI Multiple 
Deprivation Measure 2010 Super Output 
Area rank. Super Output Areas were 
assigned from patient postcodes using 
the November 2016 Central Postcode 
Directory.
      76%
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Table 2. Completeness and notes of variables in NIMATS (2010–2014).
Variable Notes Completeness of  
data/comments
1. STUDY_ID A case number numbered from 1 to 96,233. Allows data linkage 
to EPD data.
100%
2. MOTHER_ID A case number numbered from 1 to 94,545. Can be used to 
identify small number of multiple pregnancies where both births 
involved CHD.
100%
3. PARITY Number of times a woman has given birth. >99%
4. GEST_AT_BOOKING_WEEKS Gestational age at booking, measured in weeks. >99%
5. AGE_AT_BOOKING Mother’s age at booking, measured in years and grouped as 
follows: ‘<20’, ‘20-24’, ‘25-29’, ‘30-34’, ‘35-39’, ‘40-44’, ‘45+’.
>99%
6. PLANNED_PREGNANCY Yes/No. 2,524 blanks. 97%
7. FAMILY_CONGEN_
ABNORM_01_CARDIAC





Yes/No for family history of congenital anomalies of type ’02 - 
Chromosomal’.
100%
9. MOTHERS_BMI Mother’s body mass index: 3,596 missing cases due to mother’s 
height and/or weight missing. Height and weight were requested 
in the hope that additional BMI values could be calculated, but 
on inspection this variable contained values whenever both 
height and weight were recorded.
96%
10. SMOKING Cigarettes per day. >99%
11. PARTNER_SMOKING Cigarettes per day. 96%
12. ALCOHOL Units per week. >99%
13. MOTHER_FOLIC_ACID_1 Present medications – FA. 10%
14. MOTHER_FOLIC_ACID_2 Patients were observed to have up to four values recorded 
against a single pregnancy.
<1%
15. MOTHER_FOLIC_ACID_3 Patients were observed to have up to four values recorded 
against a single pregnancy.
<1%
16. MOTHER_FOLIC_ACID_4 Patients were observed to have up to four values recorded 




Present medications – all medications used including FA. 97%
18. MOTHER_PRES_
MEDICATION_2
Patients were observed to have up to eight values recorded 




Patients were observed to have up to eight values recorded 




Patients were observed to have up to eight values recorded 




Patients were observed to have up to eight values recorded 




Patients were observed to have up to eight values recorded 




Patients were observed to have up to eight values recorded 




Patients were observed to have up to eight values recorded 




Mental health disorders from previous medical history.
Patients were observed to have up to five values recorded 
against a single pregnancy.
95%
26. MENTAL_HEALTH_YEAR_1 Patients were observed to have up to five values recorded 
against a single pregnancy.




Mental health disorders from previous medical history.
Patients were observed to have up to five values recorded 
against a single pregnancy.
1%
28. MENTAL_HEALTH_YEAR_2 Patients were observed to have up to five values recorded 
against a single pregnancy.




Mental health disorders from previous medical history.
Patients were observed to have up to five values recorded 
against a single pregnancy.
<1%
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Variable Notes Completeness of  
data/comments
30. MENTAL_HEALTH_YEAR_3 Patients were observed to have up to five values recorded 
against a single pregnancy.




Mental health disorders from previous medical history.
Patients were observed to have up to five values recorded 
against a single pregnancy.
<1%
32. MENTAL_HEALTH_YEAR_4 Patients were observed to have up to five values recorded 
against a single pregnancy.




Mental health disorders from previous medical history.
Patients were observed to have up to five values recorded 
against a single pregnancy.
<1%
34. MENTAL_HEALTH_YEAR_5 Patients were observed to have up to five values recorded 
against a single pregnancy.
The year variables are not clean data.
<1%
35. CARDIO_CODE_AND_DESC_1 Cardiovascular condition from previous medical history, 
including Code 02: Congenital Heart Disease.
99%
36. CARDIO_CODE_AND_DESC_2 Patients were observed to have up to three values recorded 
against a single pregnancy.
<1%
37. CARDIO_CODE_AND_DESC_3 Patients were observed to have up to three values recorded 
against a single pregnancy.
<1%
38. STATUS_AT_BIRTH Live or still. 16 blanks. >99%
39. INFANT_BIRTH_WEIGHT Measured in grams. 116 blanks. >99%
40. INFANT_GENDER F/M. 11 cases of I, two cases of U, nine cases missing. >99%
41. PRESENT_PREG_PROB_CODE_
DESCRIPTION_1
Antenatal summary information – present pregnancy problems 
code and description.
Patients were observed to have up to nine values recorded 




Antenatal summary information – present pregnancy problems 
code and description.
Patients were observed to have up to nine values recorded 




Antenatal summary information – present pregnancy problems 
code and description.
Patients were observed to have up to nine values recorded 




Antenatal summary information – present pregnancy problems 
code and description.
Patients were observed to have up to nine values recorded 




Antenatal summary information – present pregnancy problems 
code and description.
Patients were observed to have up to nine values recorded 




Antenatal summary information – present pregnancy problems 
code and description.
Patients were observed to have up to nine values recorded 




Antenatal summary information – present pregnancy problems 
code and description.
Patients were observed to have up to nine values recorded 




Antenatal summary information – present pregnancy problems 
code and description.
Patients were observed to have up to nine values recorded 
against a single pregnancy.
<1%
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Antenatal summary information – present pregnancy problems 
code and description.
Patients were observed to have up to nine values recorded 
against a single pregnancy.
<1%
50. CONGEN_ABNORMALITY Flag variable for infant congenital abnormality (at birth). 1%






Other operative procedures code and description. Patients were 





Other operative procedures code and description. Patients were 





Other operative procedures code and description. Patients were 
observed to have up to three values recorded against a single 
pregnancy.
<1%
56. BIRTHS_THIS_PREGNANCY Number of births this pregnancy: 1, 2 or 3. 100%
57. BIRTH_NUMBER Birth number: generally, 1, 2 or 3. Two blanks. One unusual value 
of ‘6’.
>99%
58. INFANT_YEAR_OF_BIRTH Based on infant date of birth. 100%
59. MDM_QUINTILE Deprivation quintile. 1 represents the most deprived quintile and 
5 the least deprived. Calculated from the NI Multiple Deprivation 
Measure 2010 Super Output Area rank. Super Output Areas were 
assigned from patient postcodes using the November 2016 
Central Postcode Directory.
99%
60. URBAN_RURAL Urban rural classification based on NISRA’s Review of the 
Statistical Classification and Delineation of Settlements (March 





Used to identify exposure within the exposure window 100%
Table 3. Variables and notes from EPD used in the study (2010–2014).
Variable Notes
1. STUDY_ID (by using mother’s HCN number) A case number from 1 to 96,233. Allows linkage to NIMATS data.
2. NAME_FORM_STRENGTH Generic/brand name. Contains the name, form and strength of the  
medicinal product.
3. FORM_DMD Medicinal product form/presentation, e.g. tablet, capsule.
4. STRENGTH_DMD Medicinal product strength. The amount of the active ingredient that is present 
in each dosage.
5. DISPENSED_QUANTITY_VALUE The quantity of tablets, capsules, liquid etc. dispensed.
6. DDD Defined daily dose.
7. DDD_PER_UNIT Derived daily dose per quantity, calculated by the Business Services 
Organisation. For use in calculation: (DDD_PER_UNIT * QUANTITY)/number  
of days. 
8. BNF_CHAPTER British National Formulary Chapter
9. BNF_SECTION British National Formulary Section
10. BNF_PARAGRAPH British National Formulary Paragraph
11. PRESCRIPTION_CATEGORY_IND Indicator of type of prescription. M=multiple dispensed, N=normal, R=repeat 
dispensed, S=substitute.
12. ISSUE_DATE The date the prescription was dispensed by the pharmacy. For HBS use only to 
calculate Exposure Window (EW). 
13. SPECIFIED_MEDICATION Flag variable 0/1, indicating whether the prescribed medication was one of 
the medications specified in Section C2 of the project application form. Other 
medications were extracted to allow for consideration of co-medications.
14. EXPOSURE_TO_COMEDS_IN_EW Y/N. Exposure to co-medications during the exposure window.
15. MULTIPLE_BNF_CODES_Y_N Y/N. Flag variable that identifies where a medication has more than one BNF 
code.
16. MULTIPLE_BNF_CODES If MULTIPLE_BNF_CODES=Y, the BNF codes are listed here, separated by a 
semicolon.
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